Document is current
Any future updates will be listed below
-
Authors
Holmström, Morten Orebo http://orcid.org/0000-0002-3764-8578
Mortensen, Rasmus Erik Johansson
Pavlidis, Angelos Michail
Martinenaite, Evelina
Weis-Banke, Stine Emilie
Aaboe-Jørgensen, Mia
Bendtsen, Simone Kloch
Met, Özcan
Pedersen, Ayako Wakatsuki
Donia, Marco
Svane, Inge Marie
Andersen, Mads Hald
- License Information
-
More Information
Article History
Received: 18 September 2020
Revised: 5 November 2020
Accepted: 6 November 2020
First Online: 6 January 2021
Competing interests
: It should be noted, however, that Mads Hald Andersen has generated an invention based on the use of TGFβ for vaccinations. The rights to the invention have been transferred to Copenhagen University Hospital Herlev according to the Danish Law of Public Inventions at Public Research Institutions. The capital region has licensed the rights to the company IO Biotech ApS. The patent application was filed by IO Biotech ApS. Mads Hald Andersen is a board member, consultant, and shareholder in IO Biotech. Evelina Martinenaite and Ayako Wakatsuki Pedersen are employees at IO Biotech ApS. Inge Marie Svane is a consultant and shareholder in IO Biotech. The remaining authors declare no competing interests.
